256 related articles for article (PubMed ID: 36333618)
21. Generalized pustular psoriasis successfully treated with spesolimab: A case report.
Brigenti N; Gisondi P; Bellinato F; Girolomoni G
SAGE Open Med Case Rep; 2024; 12():2050313X241235451. PubMed ID: 38419797
[TBL] [Abstract][Full Text] [Related]
22. Exploring the Quality-of-Life Impact, Disease Burden, and Management Challenges of GPP: The Provider and Patient Perspective [Podcast].
Hawkes JE; Reisner DV; Bhutani T
Clin Cosmet Investig Dermatol; 2023; 16():3333-3339. PubMed ID: 38021429
[TBL] [Abstract][Full Text] [Related]
23. Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment.
Rivera-Díaz R; Daudén E; Carrascosa JM; Cueva P; Puig L
Dermatol Ther (Heidelb); 2023 Mar; 13(3):673-688. PubMed ID: 36635445
[TBL] [Abstract][Full Text] [Related]
24. Characteristics and management of generalized pustular psoriasis (GPP): Experience from the Central and Eastern Europe (CEE) GPP Expert Network.
Wolf P; Ceovic R; Conrad C; Falkensteiner K; Graier T; Kołt-Kamińska M; Marovt M; Mateeva V; Maul JT; Navarini AA; Nicolescu AC; Ratzinger G; Pavlovsky L; Sanzharovskaya M; Szegedi A; Reich A
J Eur Acad Dermatol Venereol; 2024 Jan; ():. PubMed ID: 38279888
[TBL] [Abstract][Full Text] [Related]
25. Psychometric validation of the generalized pustular psoriasis physician global assessment (GPPGA) and generalized pustular psoriasis area and severity index (GPPASI).
Burden AD; Bissonnette R; Lebwohl MG; Gloede T; Anatchkova M; Budhiarso I; Hu N; Thoma C; Skalicky AM; Bachelez H
J Eur Acad Dermatol Venereol; 2023 Jul; 37(7):1327-1335. PubMed ID: 36854864
[TBL] [Abstract][Full Text] [Related]
26. [Remission of recalcitrant generalized pustular psoriasis under interleukin-36 receptor inhibitor spesolimab].
Müller VL; Kreuter A
Dermatologie (Heidelb); 2023 May; 74(5):356-359. PubMed ID: 36943426
[TBL] [Abstract][Full Text] [Related]
27. Clinical advances in biological therapy for generalized pustular psoriasis: a review.
Hsieh CY; Tsai TF
Expert Opin Biol Ther; 2024; 24(1-2):37-50. PubMed ID: 38247394
[TBL] [Abstract][Full Text] [Related]
28. Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management.
Puig L; Choon SE; Gottlieb AB; Marrakchi S; Prinz JC; Romiti R; Tada Y; von Bredow D; Gooderham M
J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):737-752. PubMed ID: 36606566
[TBL] [Abstract][Full Text] [Related]
29. Current management of generalized pustular psoriasis.
Kodali N; Blanchard I; Kunamneni S; Lebwohl MG
Exp Dermatol; 2023 Aug; 32(8):1204-1218. PubMed ID: 36779681
[TBL] [Abstract][Full Text] [Related]
30. Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World Evidence.
Bhutani T; Farberg AS
Dermatol Ther (Heidelb); 2024 Feb; 14(2):341-360. PubMed ID: 38363460
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study.
Yamanaka K; Okubo Y; Yasuda I; Saito N; Messina I; Morita A
J Dermatol; 2023 Feb; 50(2):195-202. PubMed ID: 36514850
[TBL] [Abstract][Full Text] [Related]
32. Imsidolimab, an anti-interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis: results from the phase II GALLOP trial.
Warren RB; Reich A; Kaszuba A; Placek W; Griffiths CEM; Zhou J; Randazzo B; Lizzul P; Gudjonsson JE
Br J Dermatol; 2023 Jul; 189(2):161-169. PubMed ID: 37120722
[TBL] [Abstract][Full Text] [Related]
33. Rapid and sustained resolution in generalized pustular psoriasis with IL-17A inhibitors required high adherence: a 96-week analysis in a real-life setting.
Hu K; Liu Y; Liu Y; Jian L; Duan Y; Liu R; Zhang H; Chen J; Zhang M; Kuang Y
Int J Dermatol; 2024 Apr; ():. PubMed ID: 38632699
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology, Characteristics of Disease, and Unmet Needs of Patients with Generalized Pustular Psoriasis: A Large Italian Delphi Consensus.
Prignano F; Atzori L; Bellinato F; Damiani G; Galeone C; Mariani P; Potenza C; Scopinaro A; Piaserico S; Fabbrocini G;
Dermatology; 2024; 240(3):414-424. PubMed ID: 38493762
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study.
Bellinato F; Gisondi P; Marzano AV; Piaserico S; De Simone C; Damiani G; Argenziano G; Venturini M; Dapavo P; Costanzo A; Megna M; Prignano F; Burlando M; Satolli F; Carugno A; Pezzolo E; Romanelli M; Cuccia A; Girolomoni G
Vaccines (Basel); 2023 Mar; 11(4):. PubMed ID: 37112652
[TBL] [Abstract][Full Text] [Related]
36. Approach to the Epidemiology, Disease Management, and Current Challenges in the Management of Generalized Pustular Psoriasis Through a Survey Conducted Among Spanish Dermatologists.
Vilarrasa E; Rivera R; Eiris N; Carretero G; de la Cueva P; Carrascosa JM
Actas Dermosifiliogr; 2024 May; 115(5):449-457. PubMed ID: 37925068
[TBL] [Abstract][Full Text] [Related]
37. Spesolimab in the Management of Generalized Pustular Psoriasis With Concurrent Bullous Pemphigoid and Psoriasis.
Teshima R; Saito-Sasaki N; Hitaka T; Sawada Y
Cureus; 2024 May; 16(5):e60331. PubMed ID: 38883056
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the Pharmacokinetics and Safety of Spesolimab, a Humanised Anti-interleukin-36 Receptor Monoclonal Antibody, in Healthy Non-Japanese and Japanese Subjects: Results from Phase I Clinical Studies.
Joseph D; Thoma C; Haeufel T; Li X
Clin Pharmacokinet; 2022 Dec; 61(12):1771-1787. PubMed ID: 36451029
[TBL] [Abstract][Full Text] [Related]
39. A narrative review of studies assessing the quality of life in patients with generalized pustular psoriasis.
Patel PM; Sanchez-Melendez SN; Nambudiri VE
Exp Dermatol; 2023 Aug; 32(8):1227-1234. PubMed ID: 36922363
[TBL] [Abstract][Full Text] [Related]
40.
Kantaputra P; Daroontum T; Chuamanochan M; Chaowattanapanit S; Kiratikanon S; Choonhakarn C; Intachai W; Olsen B; Tongsima S; Ngamphiw C; Pontisso P; Cox TC; Ounjai P
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
